Thus, exosomes derived from CAR T cells targeting mesothelin showed surface expression of the respective CARs and CD3 and inhibited the growth of mesothelin-positive triple-negative breast cancer cells which, might be attributed to tumor cell killing by PRF and GRZB. The gene discussed is MSLN; the disease is triple-negative breast carcinoma.